Hereditary tyrosinaemia type II in a consanguineous Ashkenazi Jewish family: intrafamilial variation in phenotype; absence of parental phenotype effects on the fetus.
We describe an Ashkenazi Jewish family in which two adults, offspring of consanguineous parents, have persistent hypertyrosinaemia (770-1110 mumol/L; normal less than 110 mumol/L). The metabolic disorder in this family is apparently due to hepatic cytosolic tyrosine aminotransferase deficiency (hereditary tyrosinaemia, type II; McKusick, 276600), because it is associated with the oculocutaneous manifestations of Richner-Hanhart syndrome. The association of this syndrome with hereditary tyrosinaemia type II is presumed to be constant. It is not in this family. The affected female sib (age 41 years) has hypertyrosinaemia and oculocutaneous signs; the brother (age 39 years) has hypertyrosinemia but no oculocutaneous disease. Both sibs have two children; none has signs of a metabolic fetopathy. Maternal hypertyrosinaemia and maternal hyperphenylalaninaemia evidently constitute different risk factors for the fetus. Paternal hypertyrosinaemia is apparently not a risk to male infertility.
DeBelle Laboratory for Biochemical Genetics, Montreal Children's Hospital, Quebec, Canada.
D
D
Chitayat
A
A
Balbul
V
V
Hani
O A
OA
Mamer
C
C
Clow
C R
CR
Scriver
D000328:Adult; D000592:Amino Acid Metabolism, Inborn Errors / Q000097:blood* / Q000201:enzymology / Q000235:genetics; D003241:Consanguinity; D005260:Female; D014644:Genetic Variation; D006801:Humans; D007585:Jews; D008297:Male; D010375:Pedigree; D010641:Phenotype; D014443:Tyrosine / Q000097:blood*; D014444:Tyrosine Transaminase / Q000172:deficiency*
D014443:Tyrosine; D014444:Tyrosine Transaminase